In collaboration with Outcomes4Me, Dr. Rebecca Previs, an oncologist and recognized leader in the oncology diagnostics field, presented during the Ask the Expert webinar and discussed the definition of HER2-low, how HER2-low status influences treatment options and how personalized medicine is transforming breast cancer treatment.